The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.
about
Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid ArthritisUpdate on the pathogenesis of Scleroderma: focus on circulating progenitor cellsChemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic AgentsChemokines as effector and target molecules in vascular biologyAlternative C-Terminal Helix Orientation Alters Chemokine Function: STRUCTURE OF THE ANTI-ANGIOGENIC CHEMOKINE, CXCL4L1Vascular endothelial growth factor (VEGF) and platelet (PF-4) factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context.Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasisThe role of platelets in tumour growth.Impact of brief exercise on circulating monocyte gene and microRNA expression: implications for atherosclerotic vascular disease.PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function.Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.Joint pathology and platelet-rich plasma therapies.Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients.Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profilingPrimary 1,25-dihydroxyvitamin D3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells.Proteomic analysis of immediate-early response plasma proteins after 70% and 90% partial hepatectomy.The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier BreakdownQuantitative proteomics analysis by isobaric tags for relative and absolute quantitation identified Lumican as a potential marker for acute aortic dissectionThe Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis.VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipientsCXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunityRole of platelet chemokines, PF-4 and CTAP-III, in cancer biology.Macrophages and chemokines as mediators of angiogenesis.Influence of levamisole and other angiogenesis inhibitors on angiogenesis and endothelial cell morphology in vitroMKEY, a Peptide Inhibitor of CXCL4-CCL5 Heterodimer Formation, Protects Against Stroke in Mice.Platelet-rich plasma for managing pain and inflammation in osteoarthritis.Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase.Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection.Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR).A New Role for Helicobacter pylori Urease: Contributions to Angiogenesis.The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.Circulating levels of platelet α-granule cytokines in trauma patients.CXCL4 is a novel nickel-binding protein and augments nickel allergy.Chronic periodontitis is associated with platelet factor 4 (PF4) secretion: A pilot study.Platelet factor 4 upregulates matrix metalloproteinase-1 production in gingival fibroblasts.Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation.
P2860
Q26749294-EA2F28FE-57D0-4B0C-ABB4-2AC99D61AF8CQ26751234-2CD1C017-FE10-48FC-86B7-820FA2CD025FQ26830743-614A90E2-835E-4A3E-B9BC-C9B5685D3C79Q27024341-1F08DBD4-D486-4ACA-BE88-131C0CD4ACC9Q27677101-2FF9B16E-5C50-49DE-BAAA-75E09BE72924Q30559386-FFB95903-AA00-4F9D-872C-6820DC7B86DAQ33709419-AE89E869-24FB-4080-97B4-E111E05AD833Q33803558-530AF420-B598-45E3-A305-DB2DADD7F4DFQ33914350-F3488BF7-D18E-4FFB-9739-A8CAAF3873C2Q34181664-3744FDCD-91B8-49AA-8EAB-C7F268F4D947Q34231598-94100E7B-EB80-4D65-91C2-CE7783C5B664Q34240837-55AE1335-2EBE-44B4-BD7E-49697AC9F972Q34305848-79E878AF-7DA5-41C3-B01E-C6CD80EAA3E7Q34535488-9B49AF1C-EB81-4812-809E-E742B4DE8BFCQ34786603-4B7BD561-F319-46CC-91A5-0E9FB0EE2654Q35041471-6FF7E23F-5225-4F38-84B9-5799FC1148CDQ35046497-ABE3E1AA-F735-44E1-BCA0-B5CA009B3555Q35162977-49B4E7C1-2E9D-416C-BFE7-6F45F670C1B3Q35195333-152F70BB-ED8D-4D82-947E-04DDAFECB9B3Q35649340-BA805843-C59C-4373-8015-7F2DB4941E7AQ36065054-21D9E2EB-5D76-445E-A9C3-146CF9019252Q36187349-AB654761-85D9-48C0-9A7C-8361FFB18001Q36684948-8EE9450D-AA1C-4EF1-8A08-B5D9F5ACE1ADQ36843770-CA2B3D08-9336-42EE-944A-EA99DF5FCEC1Q36960001-B37D88AE-E22A-4FFB-8B7A-81B2C9EEE53EQ36983319-B0754807-EE6E-46D6-8789-DA410A50C125Q37226482-5BBA464D-9F3B-4DE8-A526-41E9C7C3A209Q37364433-979B84D1-F5F9-40AF-A365-B23BBC329F1CQ38147906-603C1925-D42A-4102-B34F-BE35C702D545Q38767147-23601109-CE78-4DCF-81EA-35067DC51AF4Q39029960-8B3437D7-05B2-43A4-8949-D15716ACD204Q40359006-53786FA2-332C-447C-8D69-E91CE0002DA5Q41628251-E74F9592-ADD9-41E5-9921-1AF4BA86DD5CQ42288754-EAC1A8E5-E88C-42A6-A55E-5278DCBC4BF0Q45768840-55CA1345-E4C8-485E-894A-449D5B265DC6Q47745519-37FD6065-6B2A-48DE-B409-0962BD516C86Q48102885-F370E932-FC12-4532-ABF7-243F3378D42DQ48169544-C2296EEA-23A6-49B6-BD5A-1E6EB4A2E8EEQ50863945-F843DE27-040C-4ADD-9A5F-D1DB342C76B7Q51032187-6A5E7F28-356B-4145-8714-519206DDAB6D
P2860
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The role of the CXC chemokines ...... tion, angiogenesis and cancer.
@ast
The role of the CXC chemokines ...... tion, angiogenesis and cancer.
@en
type
label
The role of the CXC chemokines ...... tion, angiogenesis and cancer.
@ast
The role of the CXC chemokines ...... tion, angiogenesis and cancer.
@en
prefLabel
The role of the CXC chemokines ...... tion, angiogenesis and cancer.
@ast
The role of the CXC chemokines ...... tion, angiogenesis and cancer.
@en
P1476
The role of the CXC chemokines ...... tion, angiogenesis and cancer.
@en
P2093
Jo Vandercappellen
P356
10.1016/J.CYTOGFR.2010.10.011
P577
2010-11-26T00:00:00Z